Related Experiment Video
Updated: Apr 10, 2026

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis
Published on: July 4, 2007
Immune reconstitution inflammatory syndrome in a patient with progressive multifocal leukoencephalopathy
Lokesh Shahani1, Minal Shah1, Shahriar Tavakoli-Tabasi2
1Department of Internal Medicine, Baylor College of Medicine, Houston, Texas, USA.
Abstract:
Progressive multifocal leukoencephalopathy (PML) is a severe opportunistic infection of the central nervous system. A 52-year-old man with HIV infection, recently started on antiretroviral therapy, presented with symptoms of mental cloudiness, blurry vision and ataxia. MRI of the brain showed nodular perivascular space enhancement with surrounding vasogenic oedema and midline shift. A lumbar puncture revealed non-inflammatory cerebrospinal fluid and was positive for JC virus. As the patient developed worsening symptoms in the setting of initiation of antiretroviral therapy with immune recovery, a diagnosis of JC virus-associated immune reconstitution inflammatory syndrome (IRIS) was made. With recent literature on the use of CCR5 antagonist maraviroc in PML, our patient was started on maraviroc and noted to have improvement in PML IRIS. This is the first case of an HIV-positive patient successfully treated for PML IRIS with maraviroc, as verified by our literature review; also, our case has clinical implications in improving outcome in PML IRIS.
Insights
Progressive multifocal leukoencephalopathy (PML) is a severe opportunistic infection. This case study highlights successful treatment of PML-associated immune reconstitution inflammatory syndrome (IRIS) in an HIV-positive patient using maraviroc.
Area of Science:
- Neuroscience
- Infectious Diseases
- Immunology
Background:
- Progressive multifocal leukoencephalopathy (PML) is a serious opportunistic central nervous system infection.
- Antiretroviral therapy initiation in HIV patients can trigger immune reconstitution inflammatory syndrome (IRIS).
More Related Videos
06:19Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
Published on: September 9, 2022
08:47Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues
Published on: May 8, 2016